Compare · DHR vs RAIN
DHR vs RAIN
Side-by-side comparison of Danaher Corporation (DHR) and Rain Enhancement Technologies Holdco Inc. (RAIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- DHR operates in Industrials, while RAIN operates in Technology - the two are in different parts of the market.
- DHR is the larger of the two at $151.82B, about 11087.1x RAIN ($13.7M).
- DHR has been more active in the news (19 items in the past 4 weeks vs 12 for RAIN).
- DHR has more recent analyst coverage (25 ratings vs 8 for RAIN).
- Company
- Danaher Corporation
- Rain Enhancement Technologies Holdco Inc.
- Price
- -
- -
- Market cap
- $151.82B
- $13.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 19
- 12
- Recent ratings
- 25
- 8
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Rain Enhancement Technologies Holdco Inc.
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is RAIN-32, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing RAIN-32 that has completed Phase II clinical trial in liposarcoma, Phase I clinical trial in solid tumors, and Phase II clinical trial in intimal sarcoma, as well as RAD52 for tumors, including breast, ovarian, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.
Latest DHR
- President & CEO Blair Rainer sold $12,736,095 worth of shares (58,255 units at $218.63) (SEC Form 4)
- Executive Vice President Riley Christopher Paul was granted 41,072 shares, increasing direct ownership by 201% to 61,472 units (SEC Form 4)
- SEC Form 4 filed by EVP & Chief Financial Officer Gugino Matthew E
- SEC Form 4 filed by SVP-Chief Legal Officer Leiken Jonathan
- SVP, Chief Science Officer Gutierrez-Ramos Jose-Carlos was granted 13,477 shares, increasing direct ownership by 71% to 32,495 units (SEC Form 4)
- SEC Form 4 filed by Executive Vice President Sawyer Montgomery Julie A
- SEC Form 4 filed by VP, Chief Accounting Officer Bouda Christopher
- Executive Vice President Milosevich Gregory M was granted 15,402 shares, increasing direct ownership by 170% to 24,467 units (SEC Form 4)
- Chairman of Exec. Committee Rales Mitchell P was granted 500,000 shares, increasing direct ownership by 939% to 553,228 units (SEC Form 4)
- Chairman Rales Steven M was granted 500,000 shares, increasing direct ownership by 16% to 3,605,808 units (SEC Form 4)
Latest RAIN
- Rain Enhancement Technologies Holdco Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Amendment: Chief Executive Officer Seidl Randy bought $104,225 worth of shares (110,000 units at $0.95), increasing direct ownership by 17% to 754,834 units (SEC Form 4)
- Rain Enhancement Technologies Recognized With 2026 "AgTech Climate Innovation of the Year" by AgTech Breakthrough
- Chief Executive Officer Seidl Randy bought $104,225 worth of shares (110,000 units at $0.95), increasing direct ownership by 17% to 754,834 units (SEC Form 4)
- SEC Form 10-Q filed by Rain Enhancement Technologies Holdco Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Rain Enhancement Technologies Holdco Inc.
- Amendment: SEC Form 3 filed by new insider Warsh Alexandra
- Amendment: SEC Form 3 filed by new insider Steele Alexandra
- Amendment: Chief Executive Officer Seidl Randy bought $100,949 worth of shares (42,514 units at $2.37), increasing direct ownership by 7% to 644,834 units (SEC Form 4)
- Rain Enhancement Technologies Reports Business Progress, Hosts Webcast Today